Is There Any Hope Left for Axsome Therapeutics?
Axsome Therapeutics (NASDAQ:AXSM) has been a zero-to-hero biotech stock. Over the past three years, its shares rose by as much as 3,600%, but have lost nearly half of their value from their January 2020 peak. It’s still a company with a lot of potential,…
